Schedule 13G ownership disclosure
Castle Biosciences Inc
Common Stock · CUSIP: 14843C105
Event date: 2024-12-31
- Filing-level shares
- 1,832,535
- Percent of class
- 6.54%
- The Vanguard Group
Shares: 1,832,535 · Class: 6.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000098
- Form type
- SCHEDULE 13G/A
- Filer
- CASTLE BIOSCIENCES INC
- CIK
- CIK 1447362
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership